Evidence map›Paper›PMID 27098652›Full record

ArticleJournal of molecular histology2016

The heparan sulphate deficient Hspg2 exon 3 null mouse displays reduced deposition of TGF-β1 in skin compared to C57BL/6 wild type mice.

Cindy Shu, Susan M Smith, James Melrose

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular histology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Effects of CD100 promote wound healing in diabetic mice.Journal of molecular histology · 2018
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Cindy ShuRaymond Purves Bone and Joint Research Laboratory, Institute of Bone and Joint Research, Kolling Institute Northern Sydney Local Health District, The Royal North Shore Hospital, Level 10, Kolling Institute, Building B6, St. Leonards, NSW, 2065, Australia.
Susan M SmithRaymond Purves Bone and Joint Research Laboratory, Institute of Bone and Joint Research, Kolling Institute Northern Sydney Local Health District, The Royal North Shore Hospital, Level 10, Kolling Institute, Building B6, St. Leonards, NSW, 2065, Australia.
James MelroseRaymond Purves Bone and Joint Research Laboratory, Institute of Bone and Joint Research, Kolling Institute Northern Sydney Local Health District, The Royal North Shore Hospital, Level 10, Kolling Institute, Building B6, St. Leonards, NSW, 2065, Australia. james.melrose@sydney.edu.au.
Northern Sydney Local Health District · AURoyal North Shore Hospital · AUUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This was an observational study where we examined the role of perlecan HS on the deposition of TGF-β1 in C57BL/6 and Hspg2(∆3-/∆3-) perlecan exon 3 null mouse skin. Despite its obvious importance in skin repair and tissue homeostasis no definitive studies have immunolocalised TGF-β1 in skin in WT or Hspg2(∆3-/∆3-) perlecan exon 3 null mice. Vertical parasagittal murine dorsal skin from 3, 6 and 12 week old C57BL/6 and Hspg2(∆3-/∆3-) mice were fixed in neutral buffered formalin, paraffin embedded and 4 μm sections stained with Mayers haematoxylin and eosin (H & E). TGF-β1 was immunolocalised using a rabbit polyclonal antibody, heat retrieval and the Envision NovaRED detection system. Immunolocalisation of TGF-β1 differed markedly in C57BL/6 and Hspg2(∆3-/∆3-) mouse skin, ablation of exon 3 of Hspg2 resulted in a very severe reduction in the deposition of TGF-β1 in skin 3-12 weeks postnatally. The reduced deposition of TGF-β1 observed in the present study would be expected to impact detrimentally on the remodelling and healing capacity of skin in mutant mice compounding on the poor wound-healing properties already reported for perlecan exon 3 null mice due to an inability to signal with FGF-2 and promote angiogenic repair processes. TGF-β1 also has cell mediated effects in tissue homeostasis and matrix stabilisation a reduction in TGF-β1 deposition would therefore be expected to detrimentally impact on skin homeostasis in the perlecan mutant mice.

Indexed as

ExonsAnimalsGenotypeHeparan SulfateHeparan Sulfate ProteoglycansImmunohistochemistryMiceMice, Inbred C57BLMice, KnockoutSkinTransforming Growth Factor beta1Heparan SulfateHeparan Sulfate ProteoglycansperlecanTransforming Growth Factor beta1HS deficiencyPerlecanSkinTGF-β

Identifiers

PMID27098652
OpenAlexW2336718069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.